MedPlus Q1 profit falls 21% despite 22% revenue growth; shares drop 17%
MedPlus Health Services reported Q1FY27 net profit of Rs 33.2 crore as EBITDA margin narrowed 140 bps to 7.1%. The pharmacy retailer also approved Rs 155 crore in Hyderabad capex.
Indian pharmacy retailer MedPlus reported Q1FY27 profit down 21.5% despite 21.8% revenue growth, as EBITDA margin contracted to 7.1%. Shares fell over 17%, while the company approved Rs 155 crore of capital expenditure in Hyderabad.
Why this matters
The Q1 result echoes MedPlus's recent signal of 22% revenue growth alongside margin contraction and follows its ₹100 crore+ Hyderabad concierge healthcare pilot commitment, indicating expansion costs remain a pressure point.
The retail-company theme is accelerating, up 984100% QoQ.